Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Nov 12, 2024
BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.
Read more at globenewswire.com15.39
-0.65 (-4.05%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (7/28/2025, 8:19:54 PM)
4.51
-0.33 (-6.82%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
